Published in Br J Dermatol on March 01, 1996
Putative mechanisms behind effects of spinal cord stimulation on vascular diseases: a review of experimental studies. Auton Neurosci (2008) 1.01
Role of nitric oxide in the regulation of microvascular perfusion in human skin in vivo. J Physiol (1999) 0.97
Vascular involvement in systemic sclerosis (scleroderma). J Inflamm Res (2011) 0.93
The impact of systemic sclerosis on arterial wall stiffness parameters and endothelial function. Clin Rheumatol (2008) 0.88
Seasonal differences in finger skin temperature and microvascular blood flow in healthy men and women are exaggerated in women with primary Raynaud's phenomenon. Br J Clin Pharmacol (2001) 0.84
Sildenafil increases digital skin blood flow during all phases of local cooling in primary Raynaud's phenomenon. Clin Pharmacol Ther (2012) 0.82
Raynaud's phenomenon: new aspects of pathogenesis and the role of nailfold videocapillaroscopy. Reumatologia (2015) 0.78
Calcium ionophores and movement of calcium ions following the physiological stimulus to a secretory process. Nature (1973) 6.09
Immortalization of hypothalamic GnRH neurons by genetically targeted tumorigenesis. Neuron (1990) 4.15
The role of the alkaline earth ions in anaphylactic histamine secretion. J Physiol (1972) 4.03
Peri-operative risk factors for acute lung injury after elective oesophagectomy. Br J Anaesth (2001) 3.47
The relationship between histamine secretion and 45calcium uptake by mast cells. J Physiol (1977) 3.02
Chronic leg ulceration with livedoid vasculitis, and response to oral ketanserin. Br J Dermatol (1989) 2.53
Structure-activity relationships for some substance P-related peptides that cause wheal and flare reactions in human skin. J Physiol (1983) 2.42
Spontaneous rupture of the oesophagus. Br J Surg (2008) 2.40
Human basophil degranulation is not triggered by very dilute antiserum against human IgE. Nature (1993) 2.34
An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. Proc Natl Acad Sci U S A (2001) 2.28
Lesions of schistosomiasis mimicking warts on the vulva. BMJ (1993) 2.25
Cromoglycate and other antiallergic drugs: a possible mechanism of action. Br Med J (1976) 2.13
The effects of substance P on histamine and 5-hydroxytryptamine release in the rat. J Physiol (1982) 1.88
Diagnosis and management of a mediastinal leak following radical oesophagectomy. Br J Surg (2001) 1.85
A possible role for cyclic AMP in the regulation of histamine secretion and the action of cromoglycate. Biochem Pharmacol (1975) 1.80
Human model of duodenogastro-oesophageal reflux in the development of Barrett's metaplasia. Br J Surg (2003) 1.74
Desensitization in the process of histamine secretion induced by antigen and dextran. J Physiol (1974) 1.74
Prospective study of routine contrast radiology after total gastrectomy. Br J Surg (2004) 1.66
The differential expression of hepatocyte growth factor and met in human placenta. J Clin Endocrinol Metab (1997) 1.59
Expression of nerve growth factor receptors in cutaneous inflammation. Br J Dermatol (1998) 1.56
Psoriasis and leukotriene B4. Lancet (1982) 1.54
Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2. Biochem Biophys Res Commun (1996) 1.53
Peptides and neurogenic inflammation. Br Med Bull (1987) 1.51
Induction of calcium flux across the rat mast cell membrane by bridging IgE receptors. Proc Natl Acad Sci U S A (1979) 1.47
Quality-of-life assessment in patients undergoing treatment for oesophageal carcinoma. Br J Surg (1995) 1.45
Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease. Cell Death Differ (2004) 1.44
Ribavirin small-particle aerosol treatment of infections caused by influenza virus strains A/Victoria/7/83 (H1N1) and B/Texas/1/84. Antimicrob Agents Chemother (1985) 1.43
Toxic pustuloderma: a self-limiting eruption. Br J Dermatol (1990) 1.41
The ability of thapsigargin and thapsigargicin to activate cells involved in the inflammatory response. Br J Pharmacol (1985) 1.40
Induction of histamine secretion by polycations. Biochim Biophys Acta (1980) 1.39
Isotretinoin treatment of severe acne in posttransplant patients taking cyclosporine. J Am Acad Dermatol (1990) 1.38
The action of lanthanum and manganese on anaphylactic histamine secretion. Br J Pharmacol (1973) 1.34
Silica-associated systemic sclerosis is clinically, serologically and immunologically indistinguishable from idiopathic systemic sclerosis. Br J Dermatol (1990) 1.33
The pharmacological control of immediate hypersensitivity. Annu Rev Pharmacol Toxicol (1981) 1.33
Vulval schistosomiasis. J R Soc Med (1993) 1.30
Prostaglandin E1 infusions for vascular insufficiency in progressive systemic sclerosis. Ann Rheum Dis (1981) 1.30
Induction of vascular endothelial growth factor and hypoxia-inducible factor-1alpha by global ischemia in rat brain. Neuroscience (2000) 1.26
Proceedings: Activation of anaphylactic histamine release by calcium and strontium ions. Br J Pharmacol (1972) 1.26
The interaction of calcium and strontium with phosphatidyl serine in the anaphylactic secretion of histamine. J Physiol (1973) 1.23
Movement of strontium ions into mast cells and its relationship to the secretory response. J Physiol (1977) 1.21
Effect of calcium on dextran-induced histamine release from isolated mast cells. Br J Pharmacol (1972) 1.19
Site of action of the antiallergic drugs cromoglycate and doxantrazole [proceedings]. Br J Pharmacol (1977) 1.18
Cutaneous responses to 12-hydroxy-5,8,10,14-eicosatetraenoic acid (12-HETE). J Invest Dermatol (1985) 1.18
Treatment of Raynaud's phenomenon by intravenous infusion of prostacyclin (PGI2). Br J Dermatol (1982) 1.17
Src-related protein tyrosine kinases are physically associated with the surface antigen CD36 in human dermal microvascular endothelial cells. FEBS Lett (1994) 1.17
The treatment of chilblains with nifedipine: the results of a pilot study, a double-blind placebo-controlled randomized study and a long-term open trial. Br J Dermatol (1989) 1.16
The effect of Mycobacterium tuberculosis on the susceptibility of human cells to the stimulatory and toxic effects of tumour necrosis factor. Immunology (1992) 1.16
Acoustic rhinometry compared with posterior rhinomanometry in the measurement of histamine- and bradykinin-induced changes in nasal airway patency. Br J Clin Pharmacol (1994) 1.15
The pattern of metastatic lymph node dissemination from adenocarcinoma of the esophagogastric junction. Surgery (2001) 1.13
Use of alarm symptoms to select dyspeptics for endoscopy causes patients with curable esophagogastric cancer to be overlooked. Surg Endosc (2006) 1.13
Induction of vascular endothelial growth factor receptors and phosphatidylinositol 3'-kinase/Akt signaling by global cerebral ischemia in the rat. Neuroscience (2000) 1.12
Focal acral hyperkeratosis. Br J Dermatol (1983) 1.11
Proceedings: 45-Calcium uptake in rat peritoneal mast cells. Br J Pharmacol (1975) 1.09
The response of early gastric cancer to proton-pump inhibitors. N Engl J Med (1998) 1.07
Effect of prostaglandins I2 and E1 on red cell deformability in patients with Raynaud's phenomenon and systemic sclerosis. Br Med J (Clin Res Ed) (1981) 1.06
Leukotriene B4-like material in scale of psoriatic skin lesions. Br J Pharmacol (1984) 1.05
Sentinel node biopsy to evaluate the metastatic dissemination of oesophageal adenocarcinoma. Br J Surg (2005) 1.05
CB1 cannabinoid receptor induction in experimental stroke. Ann Neurol (2000) 1.03
Dual effect of lanthanum on histamine release from mast cells. Nat New Biol (1972) 1.03
Some effects of calcitonin gene-related peptide in human skin and on histamine release. Br J Dermatol (1986) 1.03
A study of the histamine H2-receptor mediating relaxation of the parenchymal lung strip preparation of the guinea-pig. Br J Pharmacol (1985) 1.02
The treatment of Raynaud's phenomenon. Br J Dermatol (1986) 1.00
The stimulation of IL-2 production by anti-rheumatic drugs. Immunology (1989) 1.00
Histamine release induced by histone and phorbol ester from rat peritoneal mast cells. Eur J Pharmacol (1985) 1.00
Substance P and calcitonin gene-related peptide: effects on mast cells and in human skin. Int Arch Allergy Appl Immunol (1987) 0.98
Effects of the lupus anticoagulant in patients with systemic lupus erythematosus on endothelial cell prostacyclin release and procoagulant activity. J Invest Dermatol (1988) 0.98
Prostacyclin increases cyclic-nucleotide responsiveness of lymphocytes from patients with systemic sclerosis. Lancet (1980) 0.98
Neuropeptides induce release of nitric oxide from human dermal microvascular endothelial cells. J Invest Dermatol (1996) 0.97
Isotretinoin and eosinophilic pleural effusion. Lancet (1989) 0.97
Successful treatment of Raynaud's syndrome with Iloprost, a chemically stable prostacyclin analogue. Br J Rheumatol (1988) 0.97
Isotretinoin and lung function in systemic sclerosis. Clin Exp Dermatol (1991) 0.96
Inhibitors of nitric oxide synthase in human skin. J Invest Dermatol (1996) 0.96
Interaction of neurotensin with the substance P receptor mediating histamine release from rat mast cells and the flare in human skin. Br J Pharmacol (1982) 0.95
Histamine release induced by dextran: the nature of the dextran receptor. Eur J Pharmacol (1982) 0.95
Altered expression of the neuropeptide-processing enzyme carboxypeptidase E in the rat brain after global ischemia. J Cereb Blood Flow Metab (2001) 0.94
A decline in myometrial nitric oxide synthase expression is associated with labor and delivery. J Clin Invest (1997) 0.94
Endothelin-1 in human skin: immunolocalization, receptor binding, mRNA expression, and effects on cutaneous microvascular endothelial cells. J Invest Dermatol (1991) 0.94
Prognostic significance of peri-operative blood transfusion following radical resection for oesophageal carcinoma. Eur J Surg Oncol (2000) 0.93
Fixation, fine structure, and immunostaining for neuropeptides: perfusion versus immersion of the neuroendocrine hypothalamus. J Histochem Cytochem (1986) 0.93
The role of reactive oxygen species in triggering proliferation and IL-2 secretion in T cells. Free Radic Biol Med (1999) 0.92
Infundibular gonadotropin-releasing hormone neurons are inhibited by direct opioid and autoregulatory synapses in juvenile monkeys. Neuroendocrinology (1988) 0.92
Randomized clinical trial of omega-3 fatty acid-supplemented enteral nutrition versus standard enteral nutrition in patients undergoing oesophagogastric cancer surgery. Br J Surg (2012) 0.92
On the actions of substance P, somatostatin, and vasoactive intestinal polypeptide on rat peritoneal mast cells and in human skin. Naunyn Schmiedebergs Arch Pharmacol (1985) 0.90
Ultrastructural localization of luteinizing hormone-releasing hormone in the median eminence of the rat. Brain Res (1975) 0.90
The mechanism of spontaneous histamine release from mast cells. J Physiol (1973) 0.89
The activity of compounds extracted from feverfew on histamine release from rat mast cells. J Pharm Pharmacol (1987) 0.89
Local increase in interleukin-1-like activity following UVB irradiation of human skin in vivo. Photodermatol (1989) 0.89
The effect of captopril on cutaneous blood flow in patients with primary Raynaud's phenomenon. Br J Dermatol (1987) 0.88
Blood mononuclear cells from patients with psoriasis exhibit an enhanced adherence to cultured vascular endothelium. J Invest Dermatol (1991) 0.88
Functional maturation of the primate fetal adrenal in vivo: I. Role of insulin-like growth factors (IGFs), IGF-I receptor, and IGF binding proteins in growth regulation. Endocrinology (1996) 0.88
Leukotrienes C4 and D4 in psoriatic skin lesions. Prostaglandins (1985) 0.88
A study of the action of bradykinin and bradykinin analogues in the human nasal airway. J Physiol (1994) 0.88
Spontaneous histamine secretion from mast cells in the presence of strontium. J Physiol (1977) 0.88
The binding of [3H]-tiotidine to homogenates of guinea-pig lung parenchyma. Br J Pharmacol (1985) 0.88
Reduction by Hoe 140, the B2 kinin receptor antagonist, of antigen-induced nasal blockage. Br J Pharmacol (1994) 0.88